Vivo Capital Fund VIII, L.P., 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 26,563 shares at $22.80 ($606K) on 2020-02-04, disclosed to the SEC on 2020-02-06.
Open-market sale of $606k CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.80 | 357 | $8K | 1.3% |
| 2 | $22.80 | 2,584 | $59K | 9.7% |
| 3 | $22.80 | 2,584 | $59K | 9.7% |
| 4 | $22.80 | 10,519 | $240K | 39.6% |
| 5 | $22.80 | 10,519 | $240K | 39.6% |
| Total | $22.80 avg | 26,563 |
| $606K |
| 100% |
| Filing → |
| CRNX | BUY | 2018-07-20 | $9.8M | — | Filing → |
| MNLO | BUY | 2018-01-29 | $5.0M | — | Filing → |
| BPMX | BUY | 2017-05-01 | $2.0M | — | Filing → |